Status:
RECRUITING
Correlation and Predictive Research of Metal Elements in Radiation-Induced Oral Mucositis
Lead Sponsor:
Nanfang Hospital, Southern Medical University
Conditions:
Head and Neck Tumors
Metal
Eligibility:
All Genders
18-75 years
Brief Summary
Radiotherapy is the main treatment method for head and neck tumors. However, almost all patients with head and neck tumors will develop acute inflammatory reactions such as Radiotherapy-Induced Oral M...
Eligibility Criteria
Inclusion
- 1）Sign the informed consent form; 2) Confirmed by pathological biopsy as nasopharyngeal carcinoma or head and neck tumors; 3) Have indications for radiotherapy and voluntarily accept radiotherapy; 4) ECOG PS: 0/1; 5) Age: 18-75 years old; 6) Laboratory tests confirm good organ function.
Exclusion
- There are contraindications for radiotherapy;
- Combined with other tumors;
- Pathological sections could not be obtained;
- The patient has any serious concurrent diseases that may pose unacceptable risks or have a negative impact on trial compliance. For instance, unstable heart diseases requiring treatment, chronic hepatitis, kidney diseases with poor conditions, uncontrolled diabetes (fasting blood glucose greater than 1.5 × ULN), and mental disorders;
- The researcher judged that it was not suitable to participate in this study.
Key Trial Info
Start Date :
April 24 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 28 2026
Estimated Enrollment :
383 Patients enrolled
Trial Details
Trial ID
NCT06968520
Start Date
April 24 2025
End Date
February 28 2026
Last Update
May 13 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nanfang hospital, Southern medical university
Guangzhou, Guangdong, China, 510515